Clinical trial
Special Investigation Of Long Term Use Of Genotropin For SGA (Regulatory Post Marketing Commitment Plan)
NCT00793325 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Investigation Of Long Term Use Of Genotropin For SGA (Regulatory Post Marketing Commitment Plan)
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- December 31, 2012
- Enrollment
- 920 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
small for gestational age